Advances in surgical treatment of acute and chronic coronary artery disease

Texas Heart Institute Journal

Volumn 37, Issue 3, 2010, Pages 328-330

  Cohn, William E ^a  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ARTICLE; CARDIOPULMONARY BYPASS; CHRONIC DISEASE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; GRAFT PATENCY; HEART MUSCLE REVASCULARIZATION; HUMAN; ROBOTICS; SAPHENOUS VEIN GRAFT; STERNOTOMY; SURGICAL APPROACH; SURGICAL TECHNOLOGY; TREATMENT RESPONSE; COMPUTER ASSISTED SURGERY; GRAFT OCCLUSION, VASCULAR; OFF PUMP CORONARY SURGERY; SAPHENOUS VEIN; TIME; TRANSPLANTATION; TREATMENT OUTCOME;

ACUTE DISEASE; CHRONIC DISEASE; CORONARY ARTERY BYPASS; CORONARY ARTERY BYPASS, OFF-PUMP; CORONARY ARTERY DISEASE; GRAFT OCCLUSION, VASCULAR; HUMANS; ROBOTICS; SAPHENOUS VEIN; STERNOTOMY; SURGERY, COMPUTER-ASSISTED; TIME FACTORS; TREATMENT OUTCOME;

EID: 77955397923     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Tatoulis J, Buxton BF, Fuller JA. atencies of 2127 arterial to coronary conduits over 15 years. Ann Thorac Surg 2004;77 (1):93-101.
2. Puskas JD, Williams WH, Duke PG, Staples JR, Glas KE, Marshall JJ, et al. Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003;125 (4):797-808.
3. Cleveland JC Jr, Shroyer AL, Chen AY, Peterson E, Grover FL. Off-pump coronary artery bypass grafting decreases riskadjusted mortality and morbidity. Ann Thorac Surg 2001;72 (4):1282-1289.
4. Lee JD, Lee SJ, Tsushima WT, Yamauchi H, Lau WT, Popper J, et al. Benefits of off-pump bypass on neurologic and clinical morbidity: a prospective randomized trial. Ann Thorac Surg 2003;76(1):18-26.
5. Hernandez F, Cohn WE, Baribeau YR, Tryzelaar JF, Charlesworth DC, Clough RA, et al. In-hospital outcomes of offpump versus on-pump coronary artery bypass procedures: a multicenter experience. Ann Thorac Surg 2001;72(5):1528-1534.
6. Puskas JD, Thourani VH, Marshall JJ, Dempsey SJ, SteinerMA, Sammons BH, et al. Clinical outcomes, angiographic patency, and resource utilization in 200 consecutive off-pump coronary bypass patients. Ann Thorac Surg 2001;71(5):1477-1484.
7. Yokoyama T, Baumgartner FJ, Gheissari A, Capouya ER, Panagiotides GP, Declusin RJ. Off-pump versus on-pump coronary bypass in high-risk subgroups. Ann Thorac Surg 2000;70(5):1546-1550.
8. Dewey TM, Herbert MA, Prince SL, Robbins CL, Worley CM, Magee MJ, Mack MJ. Does coronary artery bypass graft surgery improve survival among patients with end-stage renal disease? Ann Thorac Surg 2006;81(2):591-598.
9. Sedrakyan A, Wu AW, Parashar A, Bass EB, Treasure T. Offpump surgery is associated with reduced occurrence of stroke and other morbidity as compared with traditional coronary artery bypass grafting: a meta-analysis of systematically reviewed trials. Stroke 2006;37(11):2759-2769.
10. Bucerius J, Gummert JF, Walther T, Schmitt DV, Doll N, Falk V, Mohr FW. On-pump versus off-pump coronary artery bypass grafting: impact on postoperative renal failure requiring renal replacement therapy. Ann Thorac Surg 2004;77(4): 1250-1256.
11. Zhang L, Boyce SW, Hill PC, Sun X, Lee A, Haile E, et al. Off-pump coronary artery bypass grafting improves in-hospital mortality in patients with dialysis-dependent renal failure. Cardiovasc Revasc Med 2009;10(1):12-16.
12. Shaheen AA, Kaplan GG, Hubbard JN, Myers RP. Morbidity and mortality following coronary artery bypass graft surgery in patients with cirrhosis: a population-based study. Liver Int 2009;29(8):1141-1151.
13. Khan NE, De Souza A, Mister R, Flather M, Clague J, Davies S, et al. A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery. N Engl J Med 2004;350(1):21-28.
14. Al-Ruzzeh S, George S, Bustami M, Wray J, Ilsley C, Athanasiou T, Amrani M. Effect of off-pump coronary artery bypass surgery on clinical, angiographic, neurocognitive, and quality of life outcomes: randomised controlled trial. BMJ 2006;332 (7554):1365.
15. Kobayashi J, Tashiro T, Ochi M, Yaku H, Watanabe G, Satoh T, et al. Early outcome of a randomized comparison of offpump and on-pump multiple arterial coronary revascularization. Circulation 2005;112(9 Suppl):I338-1343.
16. Omeroglu SN, Kirali K, Guler M, Toker ME, Ipek G, Isik O, Yakut C. Midterm angiographic assessment of coronary artery bypass grafting without cardiopulmonary bypass. Ann Thorac Surg 2000;70(3):844-850.
17. Puskas JD, Williams WH, Mahoney EM, Huber PR, Block PC, Duke PG, et al. Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trial. JAMA 2004; 291(15):1841-1849.
18. Loop FD, Cosgrove DM, Lytle BW, Thurer RL, Simpfendorfer C, Taylor PC, Proudfit WL. An 11 year evolution of coronary arterial surgery (1968-1978). Ann Surg 1979;190(4): 444-455.
19. Lytle BW, Loop FD, Cosgrove DM, Ratliff NB, Easley K, Taylor PC. Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg 1985;89(2):248-258.
20. Alexander JH, Ferguson TB Jr, Joseph DM, Mack MJ, Wolf RK, Gibson CM, et al. The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics. Am Heart J 2005;150(4):643-649.
21. Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson TB Jr, Lorenz TJ, et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA 2005; 294(19):2446-2454.
22. Zilla P, Human P, Wolf M, Lichtenberg W, Rafiee N, Bezuidenhout D, et al. Constrictive external nitinol meshes inhibit vein graft intimal hyperplasia in nonhuman primates. J Thorac Cardiovasc Surg 2008;136(3):717-725.
23. Zilla P, Wolf M, Rafiee N, Moodley L, Bezuidenhout D, Black M, et al. Utilization of shape memory in external veingraft meshes allows extreme diameter constriction for suppressing intimal hyperplasia: a non-human primate study. J Vasc Surg 2009;49(6):1532-1542.
24. Argenziano M, Katz M, Bonatti J, Srivastava S, Murphy D, Poirier R, et al. Results of the prospective multicenter trial of robotically assisted totally endoscopic coronary artery bypass grafting. Ann Thorac Surg 2006;81(5):1666-1675.
25. Bonatti J, Schachner T, Bonaros N, Oehlinger A, Danzmayr M, Ruetzler E, et al. Ongoing procedure development in robotically assisted totally endoscopic coronary artery bypass grafting (TECAB). Heart Surg Forum 2005;8(4):E287-E291.
26. Bonatti J, Schachner T, Bonaros N, Oehlinger A, Wiedemann D, Ruetzler E, et al. Effectiveness and safety of total endoscopic left internal mammary artery bypass graft to the left anterior descending artery. Am J Cardiol 2009;104(12):1684-1688.
27. de Canniere D, Wimmer-Greinecker G, Cichon R, Gulielmos V, Van Praet F, Seshadri-Kreaden U, Falk V. Feasibility, safety, and efficacy of totally endoscopic coronary artery bypass grafting: multicenter European experience. J Thorac Cardiovasc Surg 2007;134(3):710-716.
28. Gummert JF, Opfermann U, Jacobs S, Walther T, Kempfert J, Mohr FW, Falk V. Anastomotic devices for coronary artery bypass grafting: technological options and potential pitfalls. Comput Biol Med 2007;37(10):1384-1393.